Screener
Supernus Pharmaceuticals SUPN Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Supernus Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001356576-26-000022
FAQ
- What is Supernus Pharmaceuticals's operating margin?
- Supernus Pharmaceuticals (SUPN) reported operating margin of -7.8% in Q1 2026.
- How has Supernus Pharmaceuticals's operating margin changed year-over-year?
- Supernus Pharmaceuticals's operating margin decreased by 169.6% year-over-year, from 11.2% to -7.8%.
- What is the long-term trend for Supernus Pharmaceuticals's operating margin?
- Over 5 years (2020 to 2025), Supernus Pharmaceuticals's operating margin has grown at a -23.6% compound annual growth rate (CAGR), from 33.4% to -8.7%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Supernus Pharmaceuticals's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude